Moderna, Inc. (MRNA) RBC Capital Markets International Healthcare Convention 2026 Could 19, 2026 10:00 AM EDT
Firm Individuals
Lavina Talukdar – Senior VP & Head of Investor Relations
Presentation
Unknown Analyst
And in the present day, they’re a terrific privilege to have Moderna as a part of our 2026 International Healthcare Convention. Representing the corporate, we’ve got Lavina Talukdar as Head of Investor Relationship right here. Lavina, thanks a lot for becoming a member of us. How are you doing in the present day?
Lavina Talukdar
Senior VP & Head of Investor Relations
Nice. Thanks a lot for having us.
Unknown Analyst
That is superior. Sure. We’ve an extended record of questions right here. However perhaps earlier than we go into the person packages, let’s begin huge image. Are you able to perhaps discuss what progress has Moderna revamped the previous couple of months? And perhaps most significantly, what’s forward right here for Moderna?
Lavina Talukdar
Senior VP & Head of Investor Relations
Positive. Nice query. So I am going to begin with just like the foundations which have been laid in 2025. So we entered that yr with a bit of little bit of uncertainty given the change in administration and the transition that was going down. Nonetheless, we attempt to management what we will management and prices got here out of the infrastructure fairly considerably. We set a aim to take out $1 billion in money prices, and we took out $2 billion.
And we additionally ended the yr on the excessive finish of our income steering of $1.9 billion in gross sales, which I believe, once more, makes a very good basis or establishes what we did within the first quarter of this yr, additionally persevering with on price containment and beating gross sales expectations, primarily pushed by the place we see progress drivers this yr, the ex U.S. strategic partnerships in addition to mNEXSPIKE later within the fall to be persevering with to drive progress for us.
